Influence of Inhibitors of the Renin-angiotensin System on Risk of Acute Respiratory Distress Syndrome in Danish Hospitalized COVID-19 Patients

Overview

Journal J Hypertens

Specialty Cardiology & Vascular Diseases

Date 2020 Jul 21

PMID 32687274

Citations 4

Authors

Anders Holt

Ikram Mizrak

Morten Lamberts

Per Lav Madsen

Affiliations

Soon will be listed here.

Citing Articles

Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.

Schoning V, Hammann F Pharmaceutics. 2022; 14(9).

PMID: 36145576 PMC: 9504398. DOI: 10.3390/pharmaceutics14091828.

Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.

Loader J, Taylor F, Lampa E, Sundstrom J J Am Heart Assoc. 2022; 11(11):e025289.

PMID: 35624081 PMC: 9238740. DOI: 10.1161/JAHA.122.025289.

Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19.

Loader J, Lampa E, Gustafsson S, Cars T, Sundstrom J J Am Heart Assoc. 2021; 10(15):e021154.

PMID: 34320843 PMC: 8475700. DOI: 10.1161/JAHA.120.021154.

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic.

Gressens S, Leftheriotis G, Dussaule J, Flamant M, Levy B, Vidal-Petiot E Front Physiol. 2021; 12:624052.

PMID: 33692701 PMC: 7937723. DOI: 10.3389/fphys.2021.624052.

References

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Esler M, Esler D . Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?. J Hypertens. 2020; 38(5):781-782. DOI: 10.1097/HJH.0000000000002450. View

Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S . Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020; 382(17):1653-1659. PMC: 7121452. DOI: 10.1056/NEJMsr2005760. View

Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q . Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91-95. PMC: 7194638. DOI: 10.1016/j.ijid.2020.03.017. View